Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection
Recent articles emphasize the need to reform intellectual property protections for government-funded inventions of public health significance.

Recent articles emphasize the need to reform intellectual property protections for government-funded inventions of public health significance.

The Argentine experience offers insights to consider for countries at different stages of abortion struggles.

Event Description As one of the largest economic sectors globally, health care represents nearly 10% of GDP spending across O.E.C.D. countries. This significant activity produces an estimated 5-10% of global greenhouse gases, presenting opportunities to directly reduce this impact through changes to energy supply, waste, purchasing, and care models. Equally important, health care has a…

Debating the origins of the COVID-19 pandemic is a fool’s errand. Considering laboratory accidents writ large, however, is important.

If pharma giants truly are committed to addressing vaccine inequity, just building manufacturing capacity in Africa might not be enough.

In parallel to official channels of federal aid, American cities can play a decisive role in supporting their Ukrainian counterparts under threat.

The future of public health in an “RNA world” is on trial in a trade secrecy dispute worth $950 million.

The Truth Pill is a monumental work that convincingly shows that drug regulation is but a myth in India.

Strict, early measures did not lead to better control of the disease, in comparison to other countries in the region.

Event Description As the U.S. Supreme Court reversed half a century of jurisprudence in Dobbs, rejecting a fundamental right to abortion, courts across Latin America have made progress in the opposite direction. A so-called “Green Wave” has swept across some of the most populous countries in a region that was formerly known for having the…
